Literature DB >> 10569509

Update on oral contraceptive pills.

S L Cerel-Suhl1, B F Yeager.   

Abstract

Oral contraceptive pills are widely used and are generally safe and effective for many women. The World Health Organization has developed a risk classification system to help physicians advise patients about the safety of oral contraceptive pills. The choice of pill formulation is influenced by clinical considerations. By choosing appropriately from the available pill formulations, family physicians can minimize negative side effects and maximize noncontraceptive benefits for their patients. Additional monitoring and follow-up are necessary in special populations, such as women over 35 years of age, smokers, perimenopausal women and adolescents. Third-generation progestins are additional options for achieving noncontraceptive benefits, but their use has raised new questions about thrombogenesis. The U.S. Food and Drug Administration has labeled emergency postcoital contraception for use following unprotected coitus. Oral contraceptive pills are associated with few clinically significant drug interactions, although consideration of interactions remains important.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10569509

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

Review 1.  Emergency contraception: a review of current oral options.

Authors:  Marisa N Mendez
Journal:  West J Med       Date:  2002-05

2.  The effect of oral contraceptive different patterns of use on circulating IGF-1 and bone mineral density in healthy premenopausal women.

Authors:  Amany Y Elkazaz; Khaled Salama
Journal:  Endocrine       Date:  2014-05-27       Impact factor: 3.633

3.  Developmental exposure to xenoestrogens at low doses alters femur length and tensile strength in adult mice.

Authors:  Katherine E Pelch; Stephanie M Carleton; Charlotte L Phillips; Susan C Nagel
Journal:  Biol Reprod       Date:  2012-03-19       Impact factor: 4.285

Review 4.  Contraceptive hormone use and cardiovascular disease.

Authors:  Chrisandra L Shufelt; C Noel Bairey Merz
Journal:  J Am Coll Cardiol       Date:  2009-01-20       Impact factor: 24.094

5.  A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk.

Authors:  Kristina M Blackmore; Jody Wong; Julia A Knight
Journal:  BMC Womens Health       Date:  2011-05-20       Impact factor: 2.809

6.  Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.

Authors:  Diana Mansour; Carole Verhoeven; Werner Sommer; Edith Weisberg; Surasak Taneepanichskul; Gian Benedetto Melis; Inger Sundström-Poromaa; Tjeerd Korver
Journal:  Eur J Contracept Reprod Health Care       Date:  2011-10-13       Impact factor: 1.848

7.  Oral contraceptives modify DNA methylation and monocyte-derived macrophage function.

Authors:  Ilaria Campesi; Manuela Sanna; Angelo Zinellu; Ciriaco Carru; Laura Rubattu; Pamela Bulzomi; Giuseppe Seghieri; Giancarlo Tonolo; Mario Palermo; Giuseppe Rosano; Maria Marino; Flavia Franconi
Journal:  Biol Sex Differ       Date:  2012-01-27       Impact factor: 5.027

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.